SCHEMBL8910189

SCHEMBL8910189

O=[C]C(c1ccccc1)c1ccncc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.58
SLC6A2 P23975 3/20 0.58
SLC6A4 P31645 3/20 0.58
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GAA P10253 1/20 0.41
NOTUM Q6P988 1/20 0.41
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 3/20 0.39
LMNA P02545 2/20 0.38
CFTR P13569 1/20 0.38
GOPC Q9HD26 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910544 0.91 SLC6A2 (0.42) SLC6A3SLC6A2SLC6A4KDM4EHSD17B10
SCHEMBL158475 0.86 SRC (0.42) LMNA
SCHEMBL8910732 0.82 CFTR (0.57) SLC6A3SLC6A2SLC6A4KDM4EGAA
SCHEMBL7995238 0.78 SLC6A2 (0.58) SLC6A3SLC6A2SLC6A4GAANOTUM
SCHEMBL9180211 0.75 SLC6A3 (0.65) SLC6A3SLC6A2SLC6A4KDM4EHSD17B10
SCHEMBL9189085 0.74 IDO1 (0.48) SLC6A3SLC6A2SLC6A4KMT2AMEN1
SCHEMBL9181832 0.74 IDO1 (0.47) HSD17B10GAAKMT2AALDH1A1LMNA
SCHEMBL9180217 0.74 ALDH1A1 (0.54) SLC6A3KDM4EGAAALDH1A1LMNA
SCHEMBL8911618 0.74 CFTR (0.52) SLC6A3SLC6A2SLC6A4KDM4EHSD17B10
SCHEMBL733008 0.74 SLC6A3 (1.00) SLC6A3SLC6A2SLC6A4KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1432015-A Indazoles substituted with 1, 1-dioxoisothiazolidine useful as cell proliferation inhibitors LG CHEM INVESTMENT LTD (KR) 2003-07-23 CN disclosed
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed